Abstract
Chemokine (C-X3-C motif) ligand 1 (CX(3)CL1, also known as fractalkine) and its receptor chemokine (C-X3-C motif) receptor 1 (CX(3)CR1) are widely expressed in immune cells and non-immune cells throughout organisms. However, their expression is mostly cell type-specific in each tissue. CX(3)CR1 expression can be found in monocytes, macrophages, dendritic cells, T cells, and natural killer (NK) cells. Interaction between CX(3)CL1 and CX(3)CR1 can mediate chemotaxis of immune cells according to concentration gradient of ligands. CX(3)CR1 expressing immune cells have a main role in either pro-inflammatory or anti-inflammatory response depending on environmental condition. In a given tissue such as bone marrow, brain, lung, liver, gut, and cancer, CX(3)CR1 expressing cells can maintain tissue homeostasis. Under pathologic conditions, however, CX(3)CR1 expressing cells can play a critical role in disease pathogenesis. Here, we discuss recent progresses of CX(3)CL1/CX(3)CR1 in major tissues and their relationships with human diseases.